These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 27184470)
1. Bone marrow metastasis presenting as bicytopenia originating from hepatocellular carcinoma. Hong YM; Yoon KT; Cho M; Kang DH; Kim HW; Choi CW; Park SB; Heo J; Woo HY; Lim W; Bakhtiar Ui Islam SM Clin Mol Hepatol; 2016 Jun; 22(2):267-71. PubMed ID: 27184470 [TBL] [Abstract][Full Text] [Related]
2. The des-gamma-carboxyprothrombin for the diagnosis of hepatocellular carcinoma. Brunello F; Marcarino C; Pasquero P; Gastaldi P; Gonella S; Martini S; Calcamuggi G; Emanuelli G Ital J Gastroenterol; 1993 Jan; 25(1):9-12. PubMed ID: 7679014 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma. Bertino G; Neri S; Bruno CM; Ardiri AM; Calvagno GS; Malaguarnera M; Toro A; Malaguarnera M; Clementi S; Bertino N; Di Carlo I Minerva Med; 2011 Oct; 102(5):363-71. PubMed ID: 22193346 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the diagnostic accuracy of des-gamma-carboxy prothrombin and alpha-fetoprotein alone or in combination for hepatocellular carcinoma: A systematic review and meta-analysis. Fan J; Chen Y; Zhang D; Yao J; Zhao Z; Jiang Y; Li Y; Guo Y Surg Oncol; 2020 Sep; 34():245-255. PubMed ID: 32891338 [No Abstract] [Full Text] [Related]
6. Early detection of hepatocellular carcinoma associated with cirrhosis by combined assay of des-gamma-carboxy prothrombin and alpha-fetoprotein: a prospective study. Izuno K; Fujiyama S; Yamasaki K; Sato M; Sato T Hepatogastroenterology; 1995; 42(4):387-93. PubMed ID: 8586374 [TBL] [Abstract][Full Text] [Related]
7. [Des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma]. Yamashiki M; Kosaka Y Rinsho Byori; 1989 Feb; 37(2):118-21. PubMed ID: 2471846 [No Abstract] [Full Text] [Related]
8. Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma. Aoyagi Y; Oguro M; Yanagi M; Mita Y; Suda T; Suzuki Y; Hata K; Ichii K; Asakura H Cancer; 1996 May; 77(9):1781-6. PubMed ID: 8646674 [TBL] [Abstract][Full Text] [Related]
9. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma. Soga K; Watanabe T; Aikawa K; Toshima M; Shibasaki K; Aoyagi Y Hepatogastroenterology; 1998; 45(23):1737-41. PubMed ID: 9840138 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study. Ji J; Wang H; Li Y; Zheng L; Yin Y; Zou Z; Zhou F; Zhou W; Shen F; Gao C PLoS One; 2016; 11(4):e0153227. PubMed ID: 27070780 [TBL] [Abstract][Full Text] [Related]